-
1
-
-
0013824754
-
Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study
-
[PMID: 5837147]
-
Brocteur J, Moens C. Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study. Acta Rheumatol Scand 1965; 11: 221-230 [PMID: 5837147]
-
(1965)
Acta Rheumatol Scand
, vol.11
, pp. 221-230
-
-
Brocteur, J.1
Moens, C.2
-
2
-
-
84873020600
-
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
-
PMID: 22972046
-
Timmer A, McDonald JW, Tsoulis D.J., Macdonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; (9): CD000478 [PMID: 22972046 DOI: 10.1002/14651858.CD000478. pub3]
-
(2012)
Cochrane Database Syst Rev
, Issue.9
-
-
Timmer, A.1
McDonald, J.W.2
Tsoulis, D.J.3
Macdonald, J.K.4
-
3
-
-
84896723109
-
Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: A meta-analysis
-
PMID: 24312308
-
Gong J, Zhu L, Guo Z., Li Y, Zhu W, Li N., Li J. Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. PLoS One 2013; 8: e81487 [PMID: 24312308 DOI: 10.1371/journal.pone.0081487]
-
(2013)
PLoS One
, vol.8
-
-
Gong, J.1
Zhu, L.2
Guo, Z.3
Li, Y.4
Zhu, W.5
Li, N.6
Li, J.7
-
4
-
-
84908245513
-
Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: A meta-analysis
-
e1 PMID: 24907505
-
Jess T, Lopez A, Andersson M., Beaugerie L, Peyrin-Biroulet L. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis. Clin Gastroenterol Hepatol 2014; 12: 1793-1800.e1 [PMID: 24907505 DOI: 10.1016/j. cgh.2014.05.019]
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 1793-1800
-
-
Jess, T.1
Lopez, A.2
Andersson, M.3
Beaugerie, L.4
Peyrin-Biroulet, L.5
-
5
-
-
84907222744
-
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease
-
PMID: 25081347
-
Gordon M, Taylor K, Akobeng A.K., Thomas AG. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2014; 8: CD010233 [PMID: 25081347 DOI: 10.1002/14651858.CD010233. pub2]
-
(2014)
Cochrane Database Syst Rev
, vol.8
-
-
Gordon, M.1
Taylor, K.2
Akobeng, A.K.3
Thomas, A.G.4
-
6
-
-
84979863815
-
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
-
PMID: 26517527
-
Chande N, Patton PH, Tsoulis D.J., Thomas BS, MacDonald JK. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2015; 10: CD000067 [PMID: 26517527 DOI: 10.1002/14651858.CD000067.pub3]
-
(2015)
Cochrane Database Syst Rev
, vol.10
-
-
Chande, N.1
Patton, P.H.2
Tsoulis, D.J.3
Thomas, B.S.4
MacDonald, J.K.5
-
7
-
-
0033794050
-
Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine
-
[PMID: 11052324]
-
Bowen DG, Selby WS Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine. Dig Dis Sci 2000; 45: 1810-1813 [PMID: 11052324]
-
(2000)
Dig Dis Sci
, vol.45
, pp. 1810-1813
-
-
Bowen, D.G.1
Selby, W.S.2
-
8
-
-
0028790186
-
A controlled double blind study of azathioprine in the management of Crohn's disease
-
[PMID: 8549944]
-
Candy S, Wright J, Gerber M., Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-678 [PMID: 8549944]
-
(1995)
Gut
, vol.37
, pp. 674-678
-
-
Candy, S.1
Wright, J.2
Gerber, M.3
Adams, G.4
Gerig, M.5
Goodman, R.6
-
9
-
-
0033770169
-
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
-
[PMID: 11040176]
-
Markowitz J, Grancher K, Kohn N., Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902 [PMID: 11040176]
-
(2000)
Gastroenterology
, vol.119
, pp. 895-902
-
-
Markowitz, J.1
Grancher, K.2
Kohn, N.3
Lesser, M.4
Daum, F.5
-
10
-
-
0018888679
-
Treatment of Crohn's disease with 6-mercaptopurine. A longterm, randomized, double-blind study
-
PMID: 6102739
-
Present DH, Korelitz BI, Wisch N, Glass J.L., Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A longterm, randomized, double-blind study. N Engl J Med 1980; 302: 981-987 [PMID: 6102739 DOI: 10.1056/NEJM198005013021801]
-
(1980)
N Engl J Med
, vol.302
, pp. 981-987
-
-
Present, D.H.1
Korelitz, B.I.2
Wisch, N.3
Glass, J.L.4
Sachar, D.B.5
Pasternack, B.S.6
-
11
-
-
0016171750
-
Treatment of Crohn's disease with azathioprine: A controlled evaluation
-
[PMID: 4597093]
-
Klein M, Binder HJ, Mitchell M, Aaronson R., Spiro H. Treatment of Crohn's disease with azathioprine: a controlled evaluation. Gastroenterology 1974; 66: 916-922 [PMID: 4597093]
-
(1974)
Gastroenterology
, vol.66
, pp. 916-922
-
-
Klein, M.1
Binder, H.J.2
Mitchell, M.3
Aaronson, R.4
Spiro, H.5
-
12
-
-
0015220432
-
Controlled trial of azathioprine in Crohn's disease
-
[PMID: 4143532]
-
Rhodes J, Bainton D, Beck P., Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 1273-1276 [PMID: 4143532]
-
(1971)
Lancet
, vol.2
, pp. 1273-1276
-
-
Rhodes, J.1
Bainton, D.2
Beck, P.3
Campbell, H.4
-
13
-
-
0018290191
-
National cooperative Crohn's disease study: Results of drug treatment
-
[PMID: 38176]
-
Summers RW, Switz DM, Sessions J.T., Becktel JM, Best WR, Kern F, Singleton JW National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-869 [PMID: 38176]
-
(1979)
Gastroenterology
, vol.77
, pp. 847-869
-
-
Summers, R.W.1
Switz, D.M.2
Sessions, J.T.3
Becktel, J.M.4
Best, W.R.5
Kern, F.6
Singleton, J.W.7
-
14
-
-
0015246251
-
Controlled trial of azathioprine in Crohn's disease
-
[PMID: 4107900]
-
Willoughby JM, Beckett J, Kumar P.J., Dawson AM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944-947 [PMID: 4107900]
-
(1971)
Lancet
, vol.2
, pp. 944-947
-
-
Willoughby, J.M.1
Beckett, J.2
Kumar, P.J.3
Dawson, A.M.4
-
15
-
-
0030784425
-
Methotrexate in chronic active Crohn's disease: A double-blind, randomized, Israeli multicenter trial
-
[PMID: 9399753]
-
Oren R, Moshkowitz M, Odes S., Becker S, Keter D, Pomeranz I., Shirin H, Reisfeld I, Broide E., Lavy A, Fich A, Eliakim R., Patz J, Villa Y, Arber N., Gilat T. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol 1997; 92: 2203-2209 [PMID: 9399753]
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 2203-2209
-
-
Oren, R.1
Moshkowitz, M.2
Odes, S.3
Becker, S.4
Keter, D.5
Pomeranz, I.6
Shirin, H.7
Reisfeld, I.8
Broide, E.9
Lavy, A.10
Fich, A.11
Eliakim, R.12
Patz, J.13
Villa, Y.14
Arber, N.15
Gilat, T.16
-
16
-
-
0033679444
-
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease
-
[PMID: 11111780]
-
Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R. 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 1227-1233 [PMID: 11111780]
-
(2000)
Eur J Gastroenterol Hepatol
, vol.12
, pp. 1227-1233
-
-
Maté-Jiménez, J.1
Hermida, C.2
Cantero-Perona, J.3
Moreno-Otero, R.4
-
17
-
-
1542603602
-
Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: A randomised, investigator-blind study
-
[PMID: 14563183]
-
Ardizzone S, Bollani S, Manzionna G., Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis 2003; 35: 619-627 [PMID: 14563183]
-
(2003)
Dig Liver Dis
, vol.35
, pp. 619-627
-
-
Ardizzone, S.1
Bollani, S.2
Manzionna, G.3
Imbesi, V.4
Colombo, E.5
Bianchi Porro, G.6
-
18
-
-
77950988234
-
Infliximab, azathioprine, or combination therapy for Crohn's disease
-
PMID: 20393175
-
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris G.J., Kornbluth A., Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard D.L., Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395 [PMID: 20393175 DOI: 10.1056/NEJMoa0904492]
-
(2010)
N Engl J Med
, vol.362
, pp. 1383-1395
-
-
Colombel, J.F.1
Sandborn, W.J.2
Reinisch, W.3
Mantzaris, G.J.4
Kornbluth, A.5
Rachmilewitz, D.6
Lichtiger, S.7
D'Haens, G.8
Diamond, R.H.9
Broussard, D.L.10
Tang, K.L.11
Van Der Woude, C.J.12
Rutgeerts, P.13
-
19
-
-
84884369477
-
Early administration of azathioprine vs conventional management of Crohn's disease: A randomized controlled trial
-
e2; quiz e14-5 PMID: 23644079
-
Cosnes J, Bourrier A, Laharie D., Nahon S, Bouhnik Y, Carbonnel F., Allez M, Dupas JL, Reimund J.M., Savoye G., Jouet P, Moreau J, Mary J Y, Colombel JF. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology 2013; 145: 758-765.e2; quiz e14-5 [PMID: 23644079 DOI: 10.1053/j.gastro.2013.04.048]
-
(2013)
Gastroenterology
, vol.145
, pp. 758-765
-
-
Cosnes, J.1
Bourrier, A.2
Laharie, D.3
Nahon, S.4
Bouhnik, Y.5
Carbonnel, F.6
Allez, M.7
Dupas, J.L.8
Reimund, J.M.9
Savoye, G.10
Jouet, P.11
Moreau, J.12
Mary, J.Y.13
Colombel, J.F.14
-
20
-
-
84884411282
-
Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease
-
e1 PMID: 23770132
-
Panés J., López-Sanromán A, Bermejo F, García-Sánchez V, Esteve M, Torres Y, Domènech E, Piqueras M, Gomez-García M, Gutiérrez A, Taxonera C, Sans M. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Gastroenterology 2013; 145: 766-774.e1 [PMID: 23770132 DOI: 10.1053/j.gastro.2013.06.009]
-
(2013)
Gastroenterology
, vol.145
, pp. 766-774
-
-
Panés, J.1
López-Sanromán, A.2
Bermejo, F.3
García-Sánchez, V.4
Esteve, M.5
Torres, Y.6
Domènech, E.7
Piqueras, M.8
Gomez-García, M.9
Gutiérrez, A.10
Taxonera, C.11
Sans, M.12
-
21
-
-
84881273549
-
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
-
PMID: 23633304
-
Chande N, Tsoulis DJ, MacDonald JK Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2013; 4: CD000545 [PMID: 23633304 DOI: 10.1002/14651858.CD000545.pub4]
-
(2013)
Cochrane Database Syst Rev
, vol.4
-
-
Chande, N.1
Tsoulis, D.J.2
MacDonald, J.K.3
-
22
-
-
84898793295
-
Gastrointestinal Malignancy and the microbiome
-
e3 PMID: 24406471
-
Abreu MT, Peek RM Gastrointestinal malignancy and the microbiome. Gastroenterology 2014; 146: 1534-1546.e3 [PMID: 24406471 DOI: 10.1053/j.gastro.2014.01.001]
-
(2014)
Gastroenterology
, vol.146
, pp. 1534-1546
-
-
Abreu, M.T.1
Peek, R.M.2
-
23
-
-
77950654921
-
Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center
-
PMID: 19798731
-
Lazarev M, Ullman T, Schraut W.H., Kip KE, Saul M, Regueiro M. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis 2010; 16: 830-835 [PMID: 19798731 DOI: 10.1002/ibd.21118]
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 830-835
-
-
Lazarev, M.1
Ullman, T.2
Schraut, W.H.3
Kip, K.E.4
Saul, M.5
Regueiro, M.6
-
24
-
-
66149148366
-
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease
-
PMID: 19009634
-
Mantzaris GJ, Christidou A, Sfakianakis M., Roussos A, Koilakou S, Petraki K., Polyzou P. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Inflamm Bowel Dis 2009; 15: 375-382 [PMID: 19009634 DOI: 10.1002/ibd.20777]
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 375-382
-
-
Mantzaris, G.J.1
Christidou, A.2
Sfakianakis, M.3
Roussos, A.4
Koilakou, S.5
Petraki, K.6
Polyzou, P.7
-
25
-
-
4644263996
-
A prospective, randomized trial of infliximab and azathioprine for the induction and maintenance of remisssion of steroid-dependent Crohn's disease
-
Mantzaris GJ, Ployzou P, Karagiannidis A., Christidou A, Koilakou S, Tsounis D., Roussos A, Triantafyllou G, Karagiannis JA A prospective, randomized trial of infliximab and azathioprine for the induction and maintenance of remisssion of steroid-dependent Crohn's disease. Gastroenterology 2004; 126: A54
-
(2004)
Gastroenterology
, vol.126
, pp. A54
-
-
Mantzaris, G.J.1
Ployzou, P.2
Karagiannidis, A.3
Christidou, A.4
Koilakou, S.5
Tsounis, D.6
Roussos, A.7
Triantafyllou, G.8
Karagiannis, J.A.9
-
26
-
-
44649193073
-
Prevention of postoperative recurrence in Crohn's disease
-
PMID: 17967564
-
Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol 2008; 6: 616-620 [PMID: 17967564 DOI: 10.1016/j.cgh.2007.08.020]
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 616-620
-
-
Terdiman, J.P.1
-
27
-
-
84887612557
-
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study
-
PMID: 23810678
-
Armuzzi A, Felice C, Papa A., Marzo M, Pugliese D, Andrisani G., Federico F, De Vitis I, Rapaccini GL, Guidi L. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. J Crohns Colitis 2013; 7: e623-e629 [PMID: 23810678 DOI: 10.1016/j. crohns.2013.04.020]
-
(2013)
J Crohns Colitis
, vol.7
, pp. e623-e629
-
-
Armuzzi, A.1
Felice, C.2
Papa, A.3
Marzo, M.4
Pugliese, D.5
Andrisani, G.6
Federico, F.7
De Vitis, I.8
Rapaccini, G.L.9
Guidi, L.10
-
28
-
-
4444366271
-
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
-
[PMID: 15362028]
-
Ardizzone S, Maconi G, Sampietro G.M., Russo A., Radice E, Colombo E, Imbesi V., Molteni M, Danelli PG, Taschieri A.M., Bianchi Porro G. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004; 127: 730-740 [PMID: 15362028]
-
(2004)
Gastroenterology
, vol.127
, pp. 730-740
-
-
Ardizzone, S.1
Maconi, G.2
Sampietro, G.M.3
Russo, A.4
Radice, E.5
Colombo, E.6
Imbesi, V.7
Molteni, M.8
Danelli, P.G.9
Taschieri, A.M.10
Bianchi Porro, G.11
-
29
-
-
4444353986
-
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
-
[PMID: 15362027]
-
Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn M.A., Thisted RA, Cohen RD, Present DH. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127: 723-729 [PMID: 15362027]
-
(2004)
Gastroenterology
, vol.127
, pp. 723-729
-
-
Hanauer, S.B.1
Korelitz, B.I.2
Rutgeerts, P.3
Peppercorn, M.A.4
Thisted, R.A.5
Cohen, R.D.6
Present, D.H.7
-
30
-
-
33749189358
-
Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease
-
[PMID: 16966711]
-
Herfarth H, Tjaden C, Lukas M., Obermeier F, Dilger K, Müller R, Schölmerich J. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006; 55: 1525-1526 [PMID: 16966711]
-
(2006)
Gut
, vol.55
, pp. 1525-1526
-
-
Herfarth, H.1
Tjaden, C.2
Lukas, M.3
Obermeier, F.4
Dilger, K.5
Müller, R.6
Schölmerich, J.7
-
31
-
-
33847153405
-
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
-
PMID: 17304143
-
Dilger K, Schaeffeler E, Lukas M., Strauch U, Herfarth H, Müller R, Schwab M. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Ther Drug Monit 2007; 29: 1-5 [PMID: 17304143 DOI: 10.1097/FTD.0b013e3180312b9a]
-
(2007)
Ther Drug Monit
, vol.29
, pp. 1-5
-
-
Dilger, K.1
Schaeffeler, E.2
Lukas, M.3
Strauch, U.4
Herfarth, H.5
Müller, R.6
Schwab, M.7
-
32
-
-
84876403700
-
Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels
-
PMID: 23388543
-
Angelberger S, Schaeffeler E, Teml A., Petritsch W, Shonova O, Lukas M., Bar-Meir S, Dilger K, Greinwald R., Mueller R, Stange EF, Herrlinger K.R., Schwab M., Reinisch W. Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels. Inflamm Bowel Dis 2013; 19: 590-598 [PMID: 23388543 DOI: 10.1097/MIB.0b013e31827eea8b]
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 590-598
-
-
Angelberger, S.1
Schaeffeler, E.2
Teml, A.3
Petritsch, W.4
Shonova, O.5
Lukas, M.6
Bar-Meir, S.7
Dilger, K.8
Greinwald, R.9
Mueller, R.10
Stange, E.F.11
Herrlinger, K.R.12
Schwab, M.13
Reinisch, W.14
-
33
-
-
50649125243
-
A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease
-
PMID: 18671816
-
Reinisch W, Panés J, Lémann M, Schreiber S., Feagan B, Schmidt S, Sturniolo G.C., Mikhailova T., Alexeeva O, Sanna L, Haas T., Korom S, Mayer H. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. Am J Gastroenterol 2008; 103: 2284-2292 [PMID: 18671816 DOI: 10.1111/j.1572-0241.2008.02024.x]
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2284-2292
-
-
Reinisch, W.1
Panés, J.2
Lémann, M.3
Schreiber, S.4
Feagan, B.5
Schmidt, S.6
Sturniolo, G.C.7
Mikhailova, T.8
Alexeeva, O.9
Sanna, L.10
Haas, T.11
Korom, S.12
Mayer, H.13
-
34
-
-
84887237442
-
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: A randomized controlled trial
-
PMID: 24019080
-
Savarino E, Bodini G, Dulbecco P., Assandri L, Bruzzone L, Mazza F., Frigo AC, Fazio V, Marabotto E, Savarino V. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol 2013; 108: 1731-1742 [PMID: 24019080 DOI: 10.1038/ajg.2013.287]
-
(2013)
Am J Gastroenterol
, vol.108
, pp. 1731-1742
-
-
Savarino, E.1
Bodini, G.2
Dulbecco, P.3
Assandri, L.4
Bruzzone, L.5
Mazza, F.6
Frigo, A.C.7
Fazio, V.8
Marabotto, E.9
Savarino, V.10
-
35
-
-
53249097726
-
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
-
PMID: 18727929
-
D'Haens G.R., Vermeire S, Van Assche G, Noman M, Aerden I., Van Olmen G, Rutgeerts P. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008; 135: 1123-1129 [PMID: 18727929 DOI: 10.1053/j.gastro.2008.07.010]
-
(2008)
Gastroenterology
, vol.135
, pp. 1123-1129
-
-
D'Haens, G.R.1
Vermeire, S.2
Van Assche, G.3
Noman, M.4
Aerden, I.5
Van Olmen, G.6
Rutgeerts, P.7
-
36
-
-
84906790991
-
Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence
-
e1 PMID: 24440221
-
Regueiro M, Kip KE, Baidoo L, Swoger J.M., Schraut W. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence. Clin Gastroenterol Hepatol 2014; 12: 1494-1502.e1 [PMID: 24440221 DOI: 10.1016/j.cgh.2013.12.035]
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 1494-1502
-
-
Regueiro, M.1
Kip, K.E.2
Baidoo, L.3
Swoger, J.M.4
Schraut, W.5
-
37
-
-
84940793606
-
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - A POCER study analysis
-
PMID: 26314275
-
De Cruz P., Kamm MA, Hamilton A.L., Ritchie KJ, Krejany EO, Gorelik A, Liew D., Prideaux L, Lawrance IC, Andrews J.M., Bampton PA, Jakobovits S, Florin TH, Gibson P.R., Debinski H., Gearry RB, Macrae FA, Leong RW, Kronborg I, RadfordSmith G., Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond P V. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis. Aliment Pharmacol Ther 2015; 42: 867-879 [PMID: 26314275 DOI: 10.1111/apt.13353]
-
(2015)
Aliment Pharmacol Ther
, vol.42
, pp. 867-879
-
-
De Cruz, P.1
Kamm, M.A.2
Hamilton, A.L.3
Ritchie, K.J.4
Krejany, E.O.5
Gorelik, A.6
Liew, D.7
Prideaux, L.8
Lawrance, I.C.9
Andrews, J.M.10
Bampton, P.A.11
Jakobovits, S.12
Florin, T.H.13
Gibson, P.R.14
Debinski, H.15
Gearry, R.B.16
Macrae, F.A.17
Leong, R.W.18
Kronborg, I.19
RadfordSmith, G.20
Selby, W.21
Johnston, M.J.22
Woods, R.23
Elliott, P.R.24
Bell, S.J.25
Brown, S.J.26
Connell, W.R.27
Desmond, P.V.28
more..
-
38
-
-
0016607713
-
Double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis. Preliminary report
-
[PMID: 235835]
-
Caprilli R, Carratù R, Babbini M. Double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis. Preliminary report. Am J Dig Dis 1975; 20: 115-120 [PMID: 235835]
-
(1975)
Am J Dig Dis
, vol.20
, pp. 115-120
-
-
Caprilli, R.1
Carratù, R.2
Babbini, M.3
-
39
-
-
0016293798
-
Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial
-
[PMID: 4441827]
-
Jewell DP, Truelove SC Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974; 4: 627-630 [PMID: 4441827]
-
(1974)
Br Med J
, vol.4
, pp. 627-630
-
-
Jewell, D.P.1
Truelove, S.C.2
-
40
-
-
0033978036
-
Role of azathioprine in severe ulcerative colitis: One-year, placebo-controlled, randomized trial
-
[PMID: 10659481]
-
Sood A, Midha V, Sood N., Kaushal V. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastroenterol 2000; 19: 14-16 [PMID: 10659481]
-
(2000)
Indian J Gastroenterol
, vol.19
, pp. 14-16
-
-
Sood, A.1
Midha, V.2
Sood, N.3
Kaushal, V.4
-
41
-
-
29244457275
-
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
-
PMID: 15972298
-
Ardizzone S, Maconi G, Russo A., Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55: 47-53 [PMID: 15972298 DOI: 10.1136/gut.2005.068809]
-
(2006)
Gut
, vol.55
, pp. 47-53
-
-
Ardizzone, S.1
Maconi, G.2
Russo, A.3
Imbesi, V.4
Colombo, E.5
Bianchi Porro, G.6
-
42
-
-
67649867062
-
Meta-analysis: The efficacy of azathioprine and mercaptopurine in ulcerative colitis
-
PMID: 19392869
-
Gisbert JP, Linares PM, McNicholl A.G., Maté J, Gomollón F. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther 2009; 30: 126-137 [PMID: 19392869 DOI: 10.1111/j.1365-2036.2009.04023.x]
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 126-137
-
-
Gisbert, J.P.1
Linares, P.M.2
McNicholl, A.G.3
Maté, J.4
Gomollón, F.5
-
43
-
-
0036278519
-
The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review
-
[PMID: 11889067]
-
Fraser AG, Orchard TR, Jewell DP The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-489 [PMID: 11889067]
-
(2002)
Gut
, vol.50
, pp. 485-489
-
-
Fraser, A.G.1
Orchard, T.R.2
Jewell, D.P.3
-
44
-
-
0034821556
-
Oral azathioprine for steroid refractory severe ulcerative colitis
-
PMID: 11569720
-
Mantzaris GJ, Archavlis E, Kourtessas D., Amberiadis P, Triantafyllou G. Oral azathioprine for steroid refractory severe ulcerative colitis. Am J Gastroenterol 2001; 96: 2797-2798 [PMID: 11569720 DOI: 10.1111/j.1572-0241.2001.04144.x]
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2797-2798
-
-
Mantzaris, G.J.1
Archavlis, E.2
Kourtessas, D.3
Amberiadis, P.4
Triantafyllou, G.5
-
45
-
-
33845482283
-
Long term results of use of azathioprine in patients with ulcerative colitis in India
-
PMID: 17143951
-
Sood A, Midha V, Sood N., Bansal M. Long term results of use of azathioprine in patients with ulcerative colitis in India. World J Gastroenterol 2006; 12: 7332-7336 [PMID: 17143951 DOI: 10.3748/wjg.v12.i45.7332]
-
(2006)
World J Gastroenterol
, vol.12
, pp. 7332-7336
-
-
Sood, A.1
Midha, V.2
Sood, N.3
Bansal, M.4
-
46
-
-
4644338224
-
A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis
-
[PMID: 15297725]
-
Ohno K, Masunaga Y, Ogawa R., Hashiguchi M, Ogata H. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis]. Yakugaku Zasshi 2004; 124: 555-560 [PMID: 15297725]
-
(2004)
Yakugaku Zasshi
, vol.124
, pp. 555-560
-
-
Ohno, K.1
Masunaga, Y.2
Ogawa, R.3
Hashiguchi, M.4
Ogata, H.5
-
47
-
-
84892737455
-
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis
-
e3 PMID: 24512909
-
Panaccione R, Ghosh S, Middleton S., Márquez JR, Scott B.B., Flint L., van Hoogstraten HJ, Chen AC, Zheng H, Danese S, Rutgeerts P. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology 2014; 146: 392-400.e3 [PMID: 24512909 DOI: 10.1053/j.gastro.2013.10.052]
-
(2014)
Gastroenterology
, vol.146
, pp. 392-400
-
-
Panaccione, R.1
Ghosh, S.2
Middleton, S.3
Márquez, J.R.4
Scott, B.B.5
Flint, L.6
Van Hoogstraten, H.J.7
Chen, A.C.8
Zheng, H.9
Danese, S.10
Rutgeerts, P.11
-
48
-
-
0026693139
-
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis
-
[PMID: 1638191]
-
Hawthorne AB, Logan RF, Hawkey C.J., Foster PN, Axon AT, Swarbrick ET, Scott B.B., Lennard-Jones JE. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992; 305: 20-22 [PMID: 1638191]
-
(1992)
BMJ
, vol.305
, pp. 20-22
-
-
Hawthorne, A.B.1
Logan, R.F.2
Hawkey, C.J.3
Foster, P.N.4
Axon, A.T.5
Swarbrick, E.T.6
Scott, B.B.7
Lennard-Jones, J.E.8
-
49
-
-
0036255548
-
The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis
-
[PMID: 11993510]
-
Sood A, Kaushal V, Midha V., Bhatia KL, Sood N, Malhotra V. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002; 37: 270-274 [PMID: 11993510]
-
(2002)
J Gastroenterol
, vol.37
, pp. 270-274
-
-
Sood, A.1
Kaushal, V.2
Midha, V.3
Bhatia, K.L.4
Sood, N.5
Malhotra, V.6
-
50
-
-
0038374989
-
Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis
-
[PMID: 12839376]
-
Sood A, Midha V, Sood N., Avasthi G. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. Indian J Gastroenterol 2003; 22: 79-81 [PMID: 12839376]
-
(2003)
Indian J Gastroenterol
, vol.22
, pp. 79-81
-
-
Sood, A.1
Midha, V.2
Sood, N.3
Avasthi, G.4
-
51
-
-
0031467050
-
Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis
-
[PMID: 9412914]
-
Ardizzone S, Molteni P, Imbesi V., Bollani S, Bianchi Porro G. Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis. J Clin Gastroenterol 1997; 25: 330-333 [PMID: 9412914]
-
(1997)
J Clin Gastroenterol
, vol.25
, pp. 330-333
-
-
Ardizzone, S.1
Molteni, P.2
Imbesi, V.3
Bollani, S.4
Bianchi Porro, G.5
-
52
-
-
72049097420
-
Maintenance treatment with azathioprine in ulcerative colitis: Outcome and predictive factors after drug withdrawal
-
PMID: 19623172
-
Cassinotti A, Actis GC, Duca P, Massari A., Colombo E, Gai E, Annese V., D'Albasio G, Manes G, Travis S., Porro GB, Ardizzone S. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Am J Gastroenterol 2009; 104: 2760-2767 [PMID: 19623172 DOI: 10.1038/ajg.2009.410]
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 2760-2767
-
-
Cassinotti, A.1
Actis, G.C.2
Duca, P.3
Massari, A.4
Colombo, E.5
Gai, E.6
Annese, V.7
D'Albasio, G.8
Manes, G.9
Travis, S.10
Porro, G.B.11
Ardizzone, S.12
-
53
-
-
77949522476
-
Azathioprine maintains longterm steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis
-
PMID: 19705415
-
Chebli LA, Chaves LD, Pimentel F.F., Guerra DM, Barros RM, Gaburri PD, Zanini A, Chebli JM Azathioprine maintains longterm steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis. Inflamm Bowel Dis 2010; 16: 613-619 [PMID: 19705415 DOI: 10.1002/ibd.21083]
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 613-619
-
-
Chebli, L.A.1
Chaves, L.D.2
Pimentel, F.F.3
Guerra, D.M.4
Barros, R.M.5
Gaburri, P.D.6
Zanini, A.7
Chebli, J.M.8
-
54
-
-
2342420871
-
Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease
-
[PMID: 15118980]
-
Cuffari C, Dassopoulos T, Turnbough L., Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 410-417 [PMID: 15118980]
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 410-417
-
-
Cuffari, C.1
Dassopoulos, T.2
Turnbough, L.3
Thompson, R.E.4
Bayless, T.M.5
-
55
-
-
0141521863
-
Lowdose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis
-
PMID: 14505127
-
Hibi T, Naganuma M, Kitahora T., Kinjyo F, Shimoyama T. Lowdose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 2003; 38: 740-746 [PMID: 14505127 DOI: 10.1007/s00535-003-1139-2]
-
(2003)
J Gastroenterol
, vol.38
, pp. 740-746
-
-
Hibi, T.1
Naganuma, M.2
Kitahora, T.3
Kinjyo, F.4
Shimoyama, T.5
-
56
-
-
33748626581
-
Long-term effectiveness of azathioprine in IBD beyond 4 years: A European multicenter study in 1176 patients
-
PMID: 16927148
-
Holtmann MH, Krummenauer F, Claas C., Kremeyer K, Lorenz D, Rainer O., Vogel I, Böcker U, Böhm S, Büning C, Duchmann R., Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF. Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig Dis Sci 2006; 51: 1516-1524 [PMID: 16927148 DOI: 10.1007/s10620-005-9037-5]
-
(2006)
Dig Dis Sci
, vol.51
, pp. 1516-1524
-
-
Holtmann, M.H.1
Krummenauer, F.2
Claas, C.3
Kremeyer, K.4
Lorenz, D.5
Rainer, O.6
Vogel, I.7
Böcker, U.8
Böhm, S.9
Büning, C.10
Duchmann, R.11
Gerken, G.12
Herfarth, H.13
Lügering, N.14
Kruis, W.15
Reinshagen, M.16
Schmidt, J.17
Stallmach, A.18
Stein, J.19
Sturm, A.20
Galle, P.R.21
Hommes, D.W.22
D'Haens, G.23
Rutgeerts, P.24
Neurath, M.F.25
more..
-
57
-
-
3142660552
-
A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis
-
PMID: 15180735
-
Mantzaris GJ, Sfakianakis M, Archavlis E., Petraki K, Christidou A, Karagiannidis A., Triadaphyllou G. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Am J Gastroenterol 2004; 99: 1122-1128 [PMID: 15180735 DOI: 10.1111/j.1572-0241.2004.11481.x]
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1122-1128
-
-
Mantzaris, G.J.1
Sfakianakis, M.2
Archavlis, E.3
Petraki, K.4
Christidou, A.5
Karagiannidis, A.6
Triadaphyllou, G.7
-
58
-
-
0035080617
-
The risk of colorectal cancer in ulcerative colitis: A meta-analysis
-
[PMID: 11247898]
-
Eaden JA, Abrams KR, Mayberry JF The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535 [PMID: 11247898]
-
(2001)
Gut
, vol.48
, pp. 526-535
-
-
Eaden, J.A.1
Abrams, K.R.2
Mayberry, J.F.3
-
59
-
-
84987624431
-
Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. Data from the ENEIDA registry
-
PMID: 26351379
-
Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry. J Crohns Colitis 2015; 9: 1063-1070 [PMID: 26351379 DOI: 10.1093/ecco-jcc/jjv145]
-
(2015)
J Crohns Colitis
, vol.9
, pp. 1063-1070
-
-
Gordillo, J.1
Cabré, E.2
Garcia-Planella, E.3
Ricart, E.4
Ber-Nieto, Y.5
Márquez, L.6
Rodríguez-Moranta, F.7
Ponferrada, A.8
Vera, I.9
Gisbert, J.P.10
Barrio, J.11
Esteve, M.12
Merino, O.13
Muñoz, F.14
Domènech, E.15
-
60
-
-
0025092693
-
Ulcerative colitis and colorectal cancer. A population-based study
-
PMID: 2215606
-
Ekbom A, Helmick C, Zack M., Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-1233 [PMID: 2215606 DOI: 10.1056/ NEJM199011013231802]
-
(1990)
N Engl J Med
, vol.323
, pp. 1228-1233
-
-
Ekbom, A.1
Helmick, C.2
Zack, M.3
Adami, H.O.4
-
61
-
-
33644820014
-
Increased risk of intestinal cancer in Crohn's disease: A meta-analysis of population-based cohort studies
-
PMID: 16393226
-
Jess T, Gamborg M, Matzen P., Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100: 2724-2729 [PMID: 16393226 DOI: 10.1111/j.1572-0241.2005.00287.x]
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 2724-2729
-
-
Jess, T.1
Gamborg, M.2
Matzen, P.3
Munkholm, P.4
Sørensen, T.I.5
-
62
-
-
84903362755
-
Systematic review with meta-analysis: The declining risk of colorectal cancer in ulcerative colitis
-
PMID: 24612141
-
Castaño-Milla C., Chaparro M, Gisbert JP Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014; 39: 645-659 [PMID: 24612141 DOI: 10.1111/apt.12651]
-
(2014)
Aliment Pharmacol Ther
, vol.39
, pp. 645-659
-
-
Castaño-Milla, C.1
Chaparro, M.2
Gisbert, J.P.3
-
63
-
-
0028363515
-
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
-
[PMID: 7910274]
-
Connell WR, Kamm MA, Dickson M, Balkwill A.M., Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-1252 [PMID: 7910274]
-
(1994)
Lancet
, vol.343
, pp. 1249-1252
-
-
Connell, W.R.1
Kamm, M.A.2
Dickson, M.3
Balkwill, A.M.4
Ritchie, J.K.5
Lennard-Jones, J.E.6
-
64
-
-
34247564971
-
5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
-
PMID: 17206695
-
Terdiman JP, Steinbuch M, Blumentals W.A., Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 367-371 [PMID: 17206695 DOI: 10.1002/ibd.20074]
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 367-371
-
-
Terdiman, J.P.1
Steinbuch, M.2
Blumentals, W.A.3
Ullman, T.A.4
Rubin, D.T.5
-
65
-
-
26244468708
-
Chemoprevention of colorectal neoplasia in ulcerative colitis: The effect of 6-mercaptopurine
-
[PMID: 16234048]
-
Matula S, Croog V, Itzkowitz S., Harpaz N, Bodian C, Hossain S., Ullman T. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol 2005; 3: 1015-1021 [PMID: 16234048]
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, pp. 1015-1021
-
-
Matula, S.1
Croog, V.2
Itzkowitz, S.3
Harpaz, N.4
Bodian, C.5
Hossain, S.6
Ullman, T.7
-
66
-
-
33744551277
-
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study
-
PMID: 16762617
-
Velayos FS, Loftus EV, Jess T, Harmsen W.S., Bida J., Zinsmeister AR, Tremaine WJ, Sandborn WJ. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006; 130: 1941-1949 [PMID: 16762617 DOI: 10.1053/j.gastro.2006.03.028]
-
(2006)
Gastroenterology
, vol.130
, pp. 1941-1949
-
-
Velayos, F.S.1
Loftus, E.V.2
Jess, T.3
Harmsen, W.S.4
Bida, J.5
Zinsmeister, A.R.6
Tremaine, W.J.7
Sandborn, W.J.8
-
67
-
-
77954426838
-
Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population-based case-control study
-
PMID: 20104215
-
Armstrong RG, West J, Card TR Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol 2010; 105: 1604-1609 [PMID: 20104215 DOI: 10.1038/ajg.2009.745]
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1604-1609
-
-
Armstrong, R.G.1
West, J.2
Card, T.R.3
-
68
-
-
84879489455
-
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease
-
e8 PMID: 23541909
-
Beaugerie L, Svrcek M, Seksik P., Bouvier AM, Simon T, Allez M, Brixi H., Gornet JM, Altwegg R, Beau P, Duclos B., Bourreille A, Faivre J, Peyrin-Biroulet L, Fléjou JF, Carrat F. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013; 145: 166-175.e8 [PMID: 23541909 DOI: 10.1053/j.gastro.2013.03.044]
-
(2013)
Gastroenterology
, vol.145
, pp. 166-175
-
-
Beaugerie, L.1
Svrcek, M.2
Seksik, P.3
Bouvier, A.M.4
Simon, T.5
Allez, M.6
Brixi, H.7
Gornet, J.M.8
Altwegg, R.9
Beau, P.10
Duclos, B.11
Bourreille, A.12
Faivre, J.13
Peyrin-Biroulet, L.14
Fléjou, J.F.15
Carrat, F.16
-
69
-
-
34848893583
-
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
-
quiz 1340-1341 PMID: 17919486
-
Gupta RB, Harpaz N, Itzkowitz S., Hossain S, Matula S, Kornbluth A., Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133: 1099-1105; quiz 1340-1341 [PMID: 17919486 DOI: 10.1053/j.gastro.2007.08.001]
-
(2007)
Gastroenterology
, vol.133
, pp. 1099-1105
-
-
Gupta, R.B.1
Harpaz, N.2
Itzkowitz, S.3
Hossain, S.4
Matula, S.5
Kornbluth, A.6
Bodian, C.7
Ullman, T.8
-
70
-
-
0031025741
-
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
-
[PMID: 8978339]
-
Lashner BA, Provencher KS, Seidner D.L., Knesebeck A., Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112: 29-32 [PMID: 8978339]
-
(1997)
Gastroenterology
, vol.112
, pp. 29-32
-
-
Lashner, B.A.1
Provencher, K.S.2
Seidner, D.L.3
Knesebeck, A.4
Brzezinski, A.5
-
71
-
-
84878557076
-
Use of azathioprine and the risk of cancer in inflammatory bowel disease
-
PMID: 23514635
-
Pasternak B, Svanström H, Schmiegelow K., Jess T, Hviid A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol 2013; 177: 1296-1305 [PMID: 23514635 DOI: 10.1093/aje/kws375]
-
(2013)
Am J Epidemiol
, vol.177
, pp. 1296-1305
-
-
Pasternak, B.1
Svanström, H.2
Schmiegelow, K.3
Jess, T.4
Hviid, A.5
-
72
-
-
10744221150
-
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
-
[PMID: 14762782]
-
Rutter M, Saunders B, Wilkinson K., Rumbles S, Schofield G, Kamm M., Williams C, Price A, Talbot I., Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-459 [PMID: 14762782]
-
(2004)
Gastroenterology
, vol.126
, pp. 451-459
-
-
Rutter, M.1
Saunders, B.2
Wilkinson, K.3
Rumbles, S.4
Schofield, G.5
Kamm, M.6
Williams, C.7
Price, A.8
Talbot, I.9
Forbes, A.10
-
73
-
-
33745284606
-
Risk factors for colorectal cancer in Crohn's colitis: A case-control study
-
[PMID: 16775493]
-
Siegel CA, Sands BE Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis 2006; 12: 491-496 [PMID: 16775493]
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 491-496
-
-
Siegel, C.A.1
Sands, B.E.2
-
74
-
-
84878222995
-
Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer?
-
PMID: 23392347
-
Satchi M, Korelitz BI, Panagopoulos G, Bratcher J., Yu C, Atallah-Vinograd J, Schneider J. Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer? Inflamm Bowel Dis 2013; 19: 785-788 [PMID: 23392347 DOI: 10.1097/MIB.0b013e318289664c]
-
(2013)
Inflamm Bowel Dis
, vol.19
, pp. 785-788
-
-
Satchi, M.1
Korelitz, B.I.2
Panagopoulos, G.3
Bratcher, J.4
Yu, C.5
Atallah-Vinograd, J.6
Schneider, J.7
-
75
-
-
79751528883
-
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: Results from a nationwide nested case-control study
-
PMID: 21045815
-
Baars JE, Looman CW, Steyerberg E.W., Beukers R., Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011; 106: 319-328 [PMID: 21045815 DOI: 10.1038/ajg.2010.428]
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 319-328
-
-
Baars, J.E.1
Looman, C.W.2
Steyerberg, E.W.3
Beukers, R.4
Tan, A.C.5
Weusten, B.L.6
Kuipers, E.J.7
Van Der Woude, C.J.8
-
76
-
-
84855206195
-
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
-
PMID: 21602529
-
van Schaik F.D., van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Gut 2012; 61: 235-240 [PMID: 21602529 DOI: 10.1136/gut.2011.237412]
-
(2012)
Gut
, vol.61
, pp. 235-240
-
-
Van Schaik, F.D.1
Van Oijen, M.G.2
Smeets, H.M.3
Van Der Heijden, G.J.4
Siersema, P.D.5
Oldenburg, B.6
-
77
-
-
0036202803
-
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
-
[PMID: 11910342]
-
Dubinsky MC, Yang H, Hassard P.V., Seidman EG, Kam LY, Abreu MT, Targan S.R., Vasiliauskas EA. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122: 904-915 [PMID: 11910342]
-
(2002)
Gastroenterology
, vol.122
, pp. 904-915
-
-
Dubinsky, M.C.1
Yang, H.2
Hassard, P.V.3
Seidman, E.G.4
Kam, L.Y.5
Abreu, M.T.6
Targan, S.R.7
Vasiliauskas, E.A.8
-
78
-
-
77956281034
-
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
-
PMID: 20155846
-
Jharap B, Seinen ML, de Boer NK, van Ginkel JR, Linskens RK, Kneppelhout JC, Mulder CJ, van Bodegraven AA. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts. Inflamm Bowel Dis 2010; 16: 1541-1549 [PMID: 20155846 DOI: 10.1002/ibd.21221]
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 1541-1549
-
-
Jharap, B.1
Seinen, M.L.2
De Boer, N.K.3
Van Ginkel, J.R.4
Linskens, R.K.5
Kneppelhout, J.C.6
Mulder, C.J.7
Van Bodegraven, A.A.8
-
79
-
-
0029134702
-
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
-
[PMID: 7778826]
-
Pearson DC, May GR, Fick G.H., Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132-142 [PMID: 7778826]
-
(1995)
Ann Intern Med
, vol.123
, pp. 132-142
-
-
Pearson, D.C.1
May, G.R.2
Fick, G.H.3
Sutherland, L.R.4
-
80
-
-
84921430591
-
Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease
-
PMID: 10796557
-
Sandborn W, Sutherland L, Pearson D., May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2000; 2: CD000545 [PMID: 10796557 DOI: 10.1002/14651858.CD000545]
-
(2000)
Cochrane Database Syst Rev
, vol.2
-
-
Sandborn, W.1
Sutherland, L.2
Pearson, D.3
May, G.4
Modigliani, R.5
Prantera, C.6
-
81
-
-
49149112175
-
The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice
-
PMID: 18479986
-
Saibeni S, Virgilio T, D'Incà R, Spina L, Bortoli A, Paccagnella M, Peli M, Sablich R, Meucci G, Colombo E, Benedetti G, Girelli CM, Casella G, Grasso G, de Franchis R, Vecchi M. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice. Dig Liver Dis 2008; 40: 814-820 [PMID: 18479986 DOI: 10.1016/j.dld.2008.03.016]
-
(2008)
Dig Liver Dis
, vol.40
, pp. 814-820
-
-
Saibeni, S.1
Virgilio, T.2
D'Incà, R.3
Spina, L.4
Bortoli, A.5
Paccagnella, M.6
Peli, M.7
Sablich, R.8
Meucci, G.9
Colombo, E.10
Benedetti, G.11
Girelli, C.M.12
Casella, G.13
Grasso, G.14
De Franchis, R.15
Vecchi, M.16
-
82
-
-
0043011380
-
Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis
-
[PMID: 12960720]
-
Warman JI, Korelitz BI, Fleisher M.R., Janardhanam R. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 2003; 37: 220-225 [PMID: 12960720]
-
(2003)
J Clin Gastroenterol
, vol.37
, pp. 220-225
-
-
Warman, J.I.1
Korelitz, B.I.2
Fleisher, M.R.3
Janardhanam, R.4
-
83
-
-
0024457688
-
6-mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
-
[PMID: 2802419]
-
Present DH, Meltzer SJ, Krumholz M.P., Wolke A., Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641-649 [PMID: 2802419]
-
(1989)
Ann Intern Med
, vol.111
, pp. 641-649
-
-
Present, D.H.1
Meltzer, S.J.2
Krumholz, M.P.3
Wolke, A.4
Korelitz, B.I.5
-
84
-
-
36549059250
-
Mortality by medication use among patients with inflammatory bowel disease, 1996-2003
-
PMID: 18054550
-
Hutfless SM, Weng X, Liu L., Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133: 1779-1786 [PMID: 18054550 DOI: 10.1053/j.gastro.2007.09.022]
-
(2007)
Gastroenterology
, vol.133
, pp. 1779-1786
-
-
Hutfless, S.M.1
Weng, X.2
Liu, L.3
Allison, J.4
Herrinton, L.J.5
-
85
-
-
33646147141
-
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
-
PMID: 16678077
-
Lichtenstein GR, Feagan BG, Cohen R.D., Salzberg BA, Diamond RH, Chen DM, Pritchard M.L., Sandborn WJ. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006; 4: 621-630 [PMID: 16678077 DOI: 10.1016/j.cgh.2006.03.002]
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 621-630
-
-
Lichtenstein, G.R.1
Feagan, B.G.2
Cohen, R.D.3
Salzberg, B.A.4
Diamond, R.H.5
Chen, D.M.6
Pritchard, M.L.7
Sandborn, W.J.8
-
86
-
-
84866122837
-
Serious infection and mortality in patients with Crohn's disease: More than 5 years of follow-up in the TREAT™ registry
-
PMID: 22890223
-
Lichtenstein GR, Feagan BG, Cohen R.D., Salzberg BA, Diamond RH, Price S, Langholff W., Londhe A, Sandborn WJ. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol 2012; 107: 1409-1422 [PMID: 22890223 DOI: 10.1038/ajg.2012.218]
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1409-1422
-
-
Lichtenstein, G.R.1
Feagan, B.G.2
Cohen, R.D.3
Salzberg, B.A.4
Diamond, R.H.5
Price, S.6
Langholff, W.7
Londhe, A.8
Sandborn, W.J.9
-
87
-
-
41349088375
-
Risk factors for opportunistic infections in patients with inflammatory bowel disease
-
PMID: 18294633
-
Toruner M, Loftus E V, Harmsen WS, Zinsmeister A.R., Orenstein R., Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-936 [PMID: 18294633 DOI: 10.1053/j.gastro.2008.01.012]
-
(2008)
Gastroenterology
, vol.134
, pp. 929-936
-
-
Toruner, M.1
Loftus, E.V.2
Harmsen, W.S.3
Zinsmeister, A.R.4
Orenstein, R.5
Sandborn, W.J.6
Colombel, J.F.7
Egan, L.J.8
-
88
-
-
41149119335
-
Opportunistic infections in patients with inflammatory bowel disease: Prevention and diagnosis
-
PMID: 18178610
-
Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008; 57: 549-558 [PMID: 18178610 DOI: 10.1136/gut.2006.114660]
-
(2008)
Gut
, vol.57
, pp. 549-558
-
-
Viget, N.1
Vernier-Massouille, G.2
Salmon-Ceron, D.3
Yazdanpanah, Y.4
Colombel, J.F.5
-
89
-
-
56949101640
-
Immune escape by Epstein-Barr virus associated Malignancies
-
PMID: 18996483
-
Münz C., Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol 2008; 18: 381-387 [PMID: 18996483 DOI: 10.1016/j.semcancer.2008.10.002]
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 381-387
-
-
Münz, C.1
Moormann, A.2
-
90
-
-
24944519200
-
Azathioprine and UVA light generate mutagenic oxidative DNA damage
-
PMID: 16166520
-
O'Donovan P., Perrett CM, Zhang X, Montaner B., Xu YZ, Harwood CA, McGregor JM, Walker S.L., Hanaoka F., Karran P. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874 [PMID: 16166520 DOI: 10.1126/science.1114233]
-
(2005)
Science
, vol.309
, pp. 1871-1874
-
-
O'Donovan, P.1
Perrett, C.M.2
Zhang, X.3
Montaner, B.4
Xu, Y.Z.5
Harwood, C.A.6
McGregor, J.M.7
Walker, S.L.8
Hanaoka, F.9
Karran, P.10
-
91
-
-
33748987908
-
Cancer despite immuno-surveillance: Immunoselection and immunosubversion
-
PMID: 16977338
-
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immuno-surveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6: 715-727 [PMID: 16977338 DOI: 10.1038/nri1936]
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 715-727
-
-
Zitvogel, L.1
Tesniere, A.2
Kroemer, G.3
-
92
-
-
84905581315
-
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer
-
PMID: 24162591
-
Beaugerie L, Carrat F, Colombel J.F., Bouvier AM, Sokol H, Babouri A, Carbonnel F., Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L. Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut 2014; 63: 1416-1423 [PMID: 24162591 DOI: 10.1136/gutjnl-2013-305763]
-
(2014)
Gut
, vol.63
, pp. 1416-1423
-
-
Beaugerie, L.1
Carrat, F.2
Colombel, J.F.3
Bouvier, A.M.4
Sokol, H.5
Babouri, A.6
Carbonnel, F.7
Laharie, D.8
Faucheron, J.L.9
Simon, T.10
De Gramont, A.11
Peyrin-Biroulet, L.12
-
93
-
-
70449100743
-
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study
-
PMID: 19837455
-
Beaugerie L, Brousse N, Bouvier A.M., Colombel JF, Lémann M, Cosnes J., Hébuterne X, Cortot A., Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-1625 [PMID: 19837455 DOI: 10.1016/S0140-6736(09)61302-7]
-
(2009)
Lancet
, vol.374
, pp. 1617-1625
-
-
Beaugerie, L.1
Brousse, N.2
Bouvier, A.M.3
Colombel, J.F.4
Lémann, M.5
Cosnes, J.6
Hébuterne, X.7
Cortot, A.8
Bouhnik, Y.9
Gendre, J.P.10
Simon, T.11
Maynadié, M.12
Hermine, O.13
Faivre, J.14
Carrat, F.15
-
94
-
-
0032754121
-
Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine
-
PMID: 10566724
-
Korelitz BI, Mirsky FJ, Fleisher M.R., Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999; 94: 3248-3253 [PMID: 10566724 DOI: 10.1111/j.1572-0241.1999.01530.x]
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 3248-3253
-
-
Korelitz, B.I.1
Mirsky, F.J.2
Fleisher, M.R.3
Warman, J.I.4
Wisch, N.5
Gleim, G.W.6
-
95
-
-
0034764110
-
Inflammatory bowel disease is not associated with an increased risk of lymphoma
-
[PMID: 11677199]
-
Lewis JD, Bilker WB, Brensinger C, Deren J.J., Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121: 1080-1087 [PMID: 11677199]
-
(2001)
Gastroenterology
, vol.121
, pp. 1080-1087
-
-
Lewis, J.D.1
Bilker, W.B.2
Brensinger, C.3
Deren, J.J.4
Vaughn, D.J.5
Strom, B.L.6
-
96
-
-
46749126662
-
Immune surveillance of EBV-infected B cells and the development of non-hodgkin lymphomas in immunocompromised patients
-
PMID: 18452077
-
Pietersma F, Piriou E, van Baarle D. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk Lymphoma 2008; 49: 1028-1041 [PMID: 18452077 DOI: 10.1080/10428190801911662]
-
(2008)
Leuk Lymphoma
, vol.49
, pp. 1028-1041
-
-
Pietersma, F.1
Piriou, E.2
Van Baarle, D.3
-
97
-
-
78650239266
-
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease
-
e1 PMID: 20888436
-
Kotlyar DS, Osterman MT, Diamond R.H., Porter D., Blonski WC, Wasik M, Sampat S, Mendizabal M., Lin MV, Lichtenstein GR. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2011; 9: 36-41.e1 [PMID: 20888436 DOI: 10.1016/j.cgh.2010.09.016]
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 36-41
-
-
Kotlyar, D.S.1
Osterman, M.T.2
Diamond, R.H.3
Porter, D.4
Blonski, W.C.5
Wasik, M.6
Sampat, S.7
Mendizabal, M.8
Lin, M.V.9
Lichtenstein, G.R.10
-
98
-
-
84866379750
-
Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease
-
PMID: 22241664
-
Sultan K, Korelitz BI, Present D, Katz S., Sunday S, Shapira I. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 1855-1858 [PMID: 22241664 DOI: 10.1002/ibd.22866]
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 1855-1858
-
-
Sultan, K.1
Korelitz, B.I.2
Present, D.3
Katz, S.4
Sunday, S.5
Shapira, I.6
-
99
-
-
77349117814
-
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease
-
PMID: 20005977
-
Long MD, Herfarth HH, Pipkin C.A., Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010; 8: 268-274 [PMID: 20005977 DOI: 10.1016/j.cgh.2009.11.024]
-
(2010)
Clin Gastroenterol Hepatol
, vol.8
, pp. 268-274
-
-
Long, M.D.1
Herfarth, H.H.2
Pipkin, C.A.3
Porter, C.Q.4
Sandler, R.S.5
Kappelman, M.D.6
-
100
-
-
84864225717
-
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
-
e1 PMID: 22584081
-
Long MD, Martin CF, Pipkin C.A., Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012; 143: 390-399.e1 [PMID: 22584081 DOI: 10.1053/j.gastro.2012.05.004]
-
(2012)
Gastroenterology
, vol.143
, pp. 390-399
-
-
Long, M.D.1
Martin, C.F.2
Pipkin, C.A.3
Herfarth, H.H.4
Sandler, R.S.5
Kappelman, M.D.6
-
101
-
-
80054862378
-
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease
-
e1-5 PMID: 21708105
-
Peyrin-Biroulet L., Khosrotehrani K, Carrat F., Bouvier AM, Chevaux JB, Simon T, Carbonnel F., Colombel JF, Dupas JL, Godeberge P, Hugot J.P., Lémann M, Nahon S., Sabaté JM, Tucat G, Beaugerie L. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011; 141: 1621-1628.e1-5 [PMID: 21708105 DOI: 10.1053/j.gastro.2011.06.050]
-
(2011)
Gastroenterology
, vol.141
, pp. 1621-1628
-
-
Peyrin-Biroulet, L.1
Khosrotehrani, K.2
Carrat, F.3
Bouvier, A.M.4
Chevaux, J.B.5
Simon, T.6
Carbonnel, F.7
Colombel, J.F.8
Dupas, J.L.9
Godeberge, P.10
Hugot, J.P.11
Lémann, M.12
Nahon, S.13
Sabaté, J.M.14
Tucat, G.15
Beaugerie, L.16
-
102
-
-
84958841167
-
Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents
-
PMID: 26247164
-
Axelrad J, Bernheim O, Colombel J.F., Malerba S., Ananthakrishnan A, Yajnik V, Hoffman G., Agrawal M, Lukin D, Desai A., McEachern E, Bosworth B, Scherl E., Reyes A, Zaidi H, Mudireddy P., DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S. Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Clin Gastroenterol Hepatol 2016; 14: 58-64 [PMID: 26247164 DOI: 10.1016/j.cgh.2015.07.037]
-
(2016)
Clin Gastroenterol Hepatol
, vol.14
, pp. 58-64
-
-
Axelrad, J.1
Bernheim, O.2
Colombel, J.F.3
Malerba, S.4
Ananthakrishnan, A.5
Yajnik, V.6
Hoffman, G.7
Agrawal, M.8
Lukin, D.9
Desai, A.10
McEachern, E.11
Bosworth, B.12
Scherl, E.13
Reyes, A.14
Zaidi, H.15
Mudireddy, P.16
DiCaprio, D.17
Sultan, K.18
Korelitz, B.19
Wang, E.20
Williams, R.21
Chen, L.22
Katz, S.23
Itzkowitz, S.24
more..
-
103
-
-
33747377769
-
Review article: Thiopurines in inflammatory bowel disease
-
PMID: 16918876
-
Derijks LJ, Gilissen LP, Hooymans P.M., Hommes DW. Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 715-729 [PMID: 16918876 DOI: 10.1111/j.1365-2036.2006.02980.x]
-
(2006)
Aliment Pharmacol Ther
, vol.24
, pp. 715-729
-
-
Derijks, L.J.1
Gilissen, L.P.2
Hooymans, P.M.3
Hommes, D.W.4
-
104
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
[PMID: 10734022]
-
Dubinsky MC, Lamothe S, Yang H.Y., Targan SR, Sinnett D, Théorêt Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-713 [PMID: 10734022]
-
(2000)
Gastroenterology
, vol.118
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
Targan, S.R.4
Sinnett, D.5
Théorêt, Y.6
Seidman, E.G.7
-
105
-
-
0242464926
-
CD28-dependent rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes
-
PMID: 12697733
-
Tiede I, Fritz G, Strand S., Poppe D, Dvorsky R, Strand D., Lehr HA, Wirtz S, Becker C, Atreya R., Mudter J, Hildner K, Bartsch B., Holtmann M, Blumberg R, Walczak H., Iven H, Galle PR, Ahmadian MR, Neurath MF. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003; 111: 1133-1145 [PMID: 12697733 DOI: 10.1172/JCI16432]
-
(2003)
J Clin Invest
, vol.111
, pp. 1133-1145
-
-
Tiede, I.1
Fritz, G.2
Strand, S.3
Poppe, D.4
Dvorsky, R.5
Strand, D.6
Lehr, H.A.7
Wirtz, S.8
Becker, C.9
Atreya, R.10
Mudter, J.11
Hildner, K.12
Bartsch, B.13
Holtmann, M.14
Blumberg, R.15
Walczak, H.16
Iven, H.17
Galle, P.R.18
Ahmadian, M.R.19
Neurath, M.F.20
more..
-
106
-
-
0035037706
-
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
-
[PMID: 11302961]
-
Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 2001; 48: 642-646 [PMID: 11302961]
-
(2001)
Gut
, vol.48
, pp. 642-646
-
-
Cuffari, C.1
Hunt, S.2
Bayless, T.3
-
107
-
-
34247624461
-
Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease
-
PMID: 17206711
-
Morales A, Salguti S, Miao C.L., Lewis JD. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 380-385 [PMID: 17206711 DOI: 10.1002/ibd.20028]
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 380-385
-
-
Morales, A.1
Salguti, S.2
Miao, C.L.3
Lewis, J.D.4
-
108
-
-
84864069451
-
The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients
-
PMID: 22664938
-
Gao X, Zhang FB, Ding L, Liu H., Wang XD, Chen BL, Bi HC, Xiao Y.L., Zhao LZ, Chen MH, Huang M, Hu PJ The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol 2012; 24: 958-964 [PMID: 22664938 DOI: 10.1097/MEG.0b013e3283545ae3]
-
(2012)
Eur J Gastroenterol Hepatol
, vol.24
, pp. 958-964
-
-
Gao, X.1
Zhang, F.B.2
Ding, L.3
Liu, H.4
Wang, X.D.5
Chen, B.L.6
Bi, H.C.7
Xiao, Y.L.8
Zhao, L.Z.9
Chen, M.H.10
Huang, M.11
Hu, P.J.12
-
109
-
-
33646778817
-
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
-
PMID: 16633046
-
Hande S, Wilson-Rich N, Bousvaros A., Zholudev A, Maurer R, Banks P., Makrauer F, Reddy S, Burakoff R., Friedman S. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis 2006; 12: 251-257 [PMID: 16633046 DOI: 10.1097/01. MIB.0000206544.05661.9f]
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 251-257
-
-
Hande, S.1
Wilson-Rich, N.2
Bousvaros, A.3
Zholudev, A.4
Maurer, R.5
Banks, P.6
Makrauer, F.7
Reddy, S.8
Burakoff, R.9
Friedman, S.10
-
110
-
-
84884909938
-
Mechanism of allopurinol induced TPMT inhibition
-
PMID: 23770457
-
Blaker PA, Arenas-Hernandez M, Smith M.A., Shobowale-Bakre EA, Fairbanks L, Irving P.M., Sanderson JD, Marinaki AM. Mechanism of allopurinol induced TPMT inhibition. Biochem Pharmacol 2013; 86: 539-547 [PMID: 23770457 DOI: 10.1016/j.bcp.2013.06.002]
-
(2013)
Biochem Pharmacol
, vol.86
, pp. 539-547
-
-
Blaker, P.A.1
Arenas-Hernandez, M.2
Smith, M.A.3
Shobowale-Bakre, E.A.4
Fairbanks, L.5
Irving, P.M.6
Sanderson, J.D.7
Marinaki, A.M.8
-
111
-
-
24344480999
-
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
-
PMID: 16128682
-
Sparrow MP, Hande SA, Friedman S, Lim W.C., Reddy SI, Cao D, Hanauer SB. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther 2005; 22: 441-446 [PMID: 16128682 DOI: 10.1111/j.1365-2036.2005.02583.x]
-
(2005)
Aliment Pharmacol Ther
, vol.22
, pp. 441-446
-
-
Sparrow, M.P.1
Hande, S.A.2
Friedman, S.3
Lim, W.C.4
Reddy, S.I.5
Cao, D.6
Hanauer, S.B.7
-
112
-
-
76449085161
-
Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
-
PMID: 20015102
-
Ansari A, Patel N, Sanderson J., O'Donohue J, Duley JA, Florin TH Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010; 31: 640-647 [PMID: 20015102 DOI: 10.1111/j.1365-2036.2009.04221.x]
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 640-647
-
-
Ansari, A.1
Patel, N.2
Sanderson, J.3
O'Donohue, J.4
Duley, J.A.5
Florin, T.H.6
-
113
-
-
49149113484
-
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease
-
[PMID: 21960930]
-
Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2008; 4: 505-511 [PMID: 21960930]
-
(2008)
Gastroenterol Hepatol (N Y)
, vol.4
, pp. 505-511
-
-
Sparrow, M.P.1
-
114
-
-
84981275794
-
Randomized clinical trial: A pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease
-
PMID: 27686002
-
Kiszka-Kanowitz M., Theede K, Mertz-Nielsen A. Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease. Scand J Gastroenterol 2016; 51: 1470-1475 [PMID: 27686002 DOI: 10.1080/00365521.2016. 1216589]
-
(2016)
Scand J Gastroenterol
, vol.51
, pp. 1470-1475
-
-
Kiszka-Kanowitz, M.1
Theede, K.2
Mertz-Nielsen, A.3
-
115
-
-
84976324424
-
Long-term safety and efficacy of low-dose azathioprine and allopurinol cotherapy in inflammatory bowel disease: A large observational study
-
PMID: 27271488
-
Pavlidis P, Stamoulos P, Abdulrehman A., Kerr P, Bull C, Duley J., Ansari A. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study. Inflamm Bowel Dis 2016; 22: 1639-1646 [PMID: 27271488 DOI: 10.1097/MIB.0000000000000827]
-
(2016)
Inflamm Bowel Dis
, vol.22
, pp. 1639-1646
-
-
Pavlidis, P.1
Stamoulos, P.2
Abdulrehman, A.3
Kerr, P.4
Bull, C.5
Duley, J.6
Ansari, A.7
-
116
-
-
84864680763
-
Split-dose administration of thiopurine drugs: A novel and effective strategy for managing preferential 6-MMP metabolism
-
PMID: 22784257
-
Shih DQ, Nguyen M, Zheng L., Ibanez P, Mei L, Kwan L.Y., Bradford K., Ting C, Targan SR, Vasiliauskas EA Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism. Aliment Pharmacol Ther 2012; 36: 449-458 [PMID: 22784257 DOI: 10.1111/ j.1365-2036.2012.05206.x]
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 449-458
-
-
Shih, D.Q.1
Nguyen, M.2
Zheng, L.3
Ibanez, P.4
Mei, L.5
Kwan, L.Y.6
Bradford, K.7
Ting, C.8
Targan, S.R.9
Vasiliauskas, E.A.10
-
117
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
PMID: 12047962
-
Hanauer SB, Feagan BG, Lichtenstein G.R., Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf D.C., Olson A., Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-1549 [PMID: 12047962 DOI: 10.1016/S0140-6736(02)08512-4]
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
118
-
-
84878945732
-
Antibody response to infliximab and its impact on pharmacokinetics can be transient
-
PMID: 23419382
-
Vande Casteele N., Gils A, Singh S., Ohrmund L, Hauenstein S, Rutgeerts P., Vermeire S. Antibody response to infliximab and its impact on pharmacokinetics can be transient. Am J Gastroenterol 2013; 108: 962-971 [PMID: 23419382 DOI: 10.1038/ajg.2013.12]
-
(2013)
Am J Gastroenterol
, vol.108
, pp. 962-971
-
-
Vande Casteele, N.1
Gils, A.2
Singh, S.3
Ohrmund, L.4
Hauenstein, S.5
Rutgeerts, P.6
Vermeire, S.7
-
119
-
-
84941330342
-
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
-
PMID: 25336114
-
Vande Casteele N., Khanna R, Levesque B.G., Stitt L., Zou G Y, Singh S, Lockton S., Hauenstein S, Ohrmund L, Greenberg G.R., Rutgeerts PJ, Gils A, Sandborn WJ, Vermeire S, Feagan BG The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease. Gut 2015; 64: 1539-1545 [PMID: 25336114 DOI: 10.1136/gutjnl-2014-307883]
-
(2015)
Gut
, vol.64
, pp. 1539-1545
-
-
Vande Casteele, N.1
Khanna, R.2
Levesque, B.G.3
Stitt, L.4
Zou, G.Y.5
Singh, S.6
Lockton, S.7
Hauenstein, S.8
Ohrmund, L.9
Greenberg, G.R.10
Rutgeerts, P.J.11
Gils, A.12
Sandborn, W.J.13
Vermeire, S.14
Feagan, B.G.15
-
120
-
-
34548130215
-
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
-
PMID: 17229796
-
Vermeire S, Noman M, Van Assche G, Baert F, D'Haens G, Rutgeerts P. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut 2007; 56: 1226-1231 [PMID: 17229796 DOI: 10.1136/gut.2006.099978]
-
(2007)
Gut
, vol.56
, pp. 1226-1231
-
-
Vermeire, S.1
Noman, M.2
Van Assche, G.3
Baert, F.4
D'Haens, G.5
Rutgeerts, P.6
-
121
-
-
84947422075
-
Effects of concomitant immunomodulator therapy on efficacy and safety of anti-tumor necrosis factor therapy for Crohn's disease: A meta-analysis of placebo-controlled trials
-
e1-2; quiz e177-178 PMID: 26142167
-
Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L., Devlin S, Melmed GY, Tanyingoh D, Raffals L., Irving P, Kozuch P, Sparrow M., Velayos F, Bressler B, Cheifetz A., Colombel JF, Siegel CA. Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials. Clin Gastroenterol Hepatol 2015; 13: 2233-2240.e1-2; quiz e177-178 [PMID: 26142167 DOI: 10.1016/j.cgh.2015.06.034]
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 2233-2240
-
-
Jones, J.L.1
Kaplan, G.G.2
Peyrin-Biroulet, L.3
Baidoo, L.4
Devlin, S.5
Melmed, G.Y.6
Tanyingoh, D.7
Raffals, L.8
Irving, P.9
Kozuch, P.10
Sparrow, M.11
Velayos, F.12
Bressler, B.13
Cheifetz, A.14
Colombel, J.F.15
Siegel, C.A.16
-
122
-
-
84875875397
-
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
-
PMID: 23061650
-
Reenaers C, Louis E, Belaiche J., Seidel L, Keshav S, Travis S. Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther 2012; 36: 1040-1048 [PMID: 23061650 DOI: 10.1111/apt.12076]
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 1040-1048
-
-
Reenaers, C.1
Louis, E.2
Belaiche, J.3
Seidel, L.4
Keshav, S.5
Travis, S.6
-
123
-
-
84925339415
-
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease
-
e4 PMID: 25066841
-
Drobne D, Bossuyt P, Breynaert C., Cattaert T, Vande Casteele N, Compernolle G, Jürgens M, Ferrante M., Ballet V, Wollants WJ, Cleynen I, Van Steen K, Gils A, Rutgeerts P., Vermeire S, Van Assche G. Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease. Clin Gastroenterol Hepatol 2015; 13: 514-521.e4 [PMID: 25066841 DOI: 10.1016/j.cgh.2014.07.027]
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 514-521
-
-
Drobne, D.1
Bossuyt, P.2
Breynaert, C.3
Cattaert, T.4
Vande Casteele, N.5
Compernolle, G.6
Jürgens, M.7
Ferrante, M.8
Ballet, V.9
Wollants, W.J.10
Cleynen, I.11
Van Steen, K.12
Gils, A.13
Rutgeerts, P.14
Vermeire, S.15
Van Assche, G.16
-
124
-
-
84945247207
-
Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: A retrospective multicenter French experience
-
PMID: 25588386
-
Filippi J, Laharie D, Michiels C., Flamand M, Bouguen G, Nancey S., Presles E, Paul S, Schneider S., Hébuterne X, Roblin X. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience. J Crohns Colitis 2015; 9: 252-258 [PMID: 25588386 DOI: 10.1093/ ecco-jcc/jjv001]
-
(2015)
J Crohns Colitis
, vol.9
, pp. 252-258
-
-
Filippi, J.1
Laharie, D.2
Michiels, C.3
Flamand, M.4
Bouguen, G.5
Nancey, S.6
Presles, E.7
Paul, S.8
Schneider, S.9
Hébuterne, X.10
Roblin, X.11
-
125
-
-
84928628450
-
Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy
-
e3 PMID: 25562796
-
Yarur AJ, Kubiliun MJ, Czul F, Sussman D.A., Quintero MA, Jain A, Drake KA, Hauenstein S.I., Lockton S., Deshpande AR, Barkin JS, Singh S, Abreu MT Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy. Clin Gastroenterol Hepatol 2015; 13: 1118-1124.e3 [PMID: 25562796 DOI: 10.1016/j.cgh.2014.12.026]
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 1118-1124
-
-
Yarur, A.J.1
Kubiliun, M.J.2
Czul, F.3
Sussman, D.A.4
Quintero, M.A.5
Jain, A.6
Drake, K.A.7
Hauenstein, S.I.8
Lockton, S.9
Deshpande, A.R.10
Barkin, J.S.11
Singh, S.12
Abreu, M.T.13
-
126
-
-
84878237639
-
Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease
-
PMID: 23716977
-
Korelitz BI. Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. World J Gastroenterol 2013; 19: 2979-2984 [PMID: 23716977 DOI: 10.3748/wjg.v19.i20.2979]
-
(2013)
World J Gastroenterol
, vol.19
, pp. 2979-2984
-
-
Korelitz, B.I.1
-
127
-
-
84904459830
-
6-mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease
-
PMID: 24462321
-
Korelitz BI, Present DH 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease. J Crohns Colitis 2014; 8: 735-738 [PMID: 24462321 DOI: 10.1016/j.crohns.2013.12.024]
-
(2014)
J Crohns Colitis
, vol.8
, pp. 735-738
-
-
Korelitz, B.I.1
Present, D.H.2
|